| Merck (Schweiz) AG - Mavenclad 10 mg, Tabletten |
| 66831 | | 01 | | Mavenclad 10 mg | | Tabletten | | L04AA40 | | Cladribine | | 19.03.2019 | | |
|
| Composition |
| cladribinum 10.00 mg, hydroxypropylbetadexum, sorbitolum 64.04 mg, magnesii stearas, pro compresso. |
| Packungsbestandteile |
| Comprimés | | | | | Principe actif | Concentr. |
|---|
| Cladribine | 10 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Cladribine | 10 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Hydroxypropylbetadexum | | | Magnesii Stearas | | | Pro Compresso | | | Sorbitol | 64.04 mg |
| |
|
|
